arrow
Y

Yoshiro Saito

National Institute of Health Sciences
H指数:56
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of anti-drug antibodies against therapeutic monoclonal antibodies and related product in Japanese patients with rheumatoid arthritis and their clinical impact

评估抗药抗体对日本类风湿关节炎患者中治疗性单克隆抗体及相关产品的临床影响

2025-10-310
OAAI
Identification and Characterization of Three Novel Biomarkers for Mixed/Cholestatic Drug-Induced Liver Injury

三种新型混合/胆汁淤积性药物性肝损伤生物标志物的鉴定与表征

2025-09-290
OAAI
Current status of Imaging Mass Spectrometry in drug discovery and development: A survey highlighting technical challenges and future directions

成像质谱在药物发现与发展中的现状:一项强调技术挑战和未来方向的综述

2025-06-010
PRE
Versatile intact LC-MS method for evaluating the drug-antibody ratio and drug load distribution of antibody-drug conjugates in human plasma

一种用于评估抗体药物偶联物在人体血浆中药物-抗体比及药物负载分布的多功能完整LC-MS方法

2025-05-010
PRE
Association of HLA-A*11:01, HLA-B*39:01, and HLA-B*56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions
2024-05-012
PRE
Differential Effects of HLA-B*15:11 and HLA-A*31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions
2024-04-014
PRE
Significant association between HLA-B35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients
2023-01-148
PRE
Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease
2022-11-1711
OAAI
Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage
2022-10-047
OAAI
Frequency of null genotypes of glutathione S-transferase M1 and T1 in Japanese patients with drug-induced liver injury

日本药物性肝损伤患者谷胱甘肽S-转移酶M1和T1的无效基因型频率

2022-08-053
PRE